State Of Wyoming Akero Therapeutics, Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$8.0 - $15.01 $5,024 - $9,426	-628 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$12.97 - $22.26 $376 - $645	-29 Reduced 4.41%	628 $9,000
Q4 2021 Feb 11, 2022	BUY	$19.87 - $26.24 $2,046 - $2,702	103 Added 18.59%	657 $14,000
Q3 2021 Feb 11, 2022	SELL	$18.65 - $25.46 $4,214 - $5,753	-226 Reduced 28.97%	554 $12,000
Q2 2021 Feb 11, 2022	BUY	$24.81 - $32.35 $12,256 - $15,980	494 Added 172.73%	780 $19,000

Q1 2021 Feb 08, 2022	BUY	$24.04 - $34.19 $6,875 - $9,778	286 New	286 $8,000

193

74.2M

429K

591K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.09B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.